643 related articles for article (PubMed ID: 17071553)
1. Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.
Capilla J; Maffei CM; Clemons KV; Sobel RA; Stevens DA
Med Mycol; 2006 Nov; 44(7):601-10. PubMed ID: 17071553
[TBL] [Abstract][Full Text] [Related]
2. [Phenotype characterization of environmental Cryptococcus neoformans isolates].
Huérfano S; Cepero MC; Castañeda E
Biomedica; 2003 Sep; 23(3):328-40. PubMed ID: 14582336
[TBL] [Abstract][Full Text] [Related]
3. Seasonal variations in the prevalence of Cryptococcus neoformans var. grubii and Cryptococcus gattii in decayed wood inside trunk hollows of diverse tree species in north-western India: a retrospective study.
Randhawa HS; Kowshik T; Chowdhary A; Prakash A; Khan ZU; Xu J
Med Mycol; 2011 Apr; 49(3):320-3. PubMed ID: 20854229
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India.
Chowdhary A; Randhawa HS; Sundar G; Kathuria S; Prakash A; Khan Z; Sun S; Xu J
J Med Microbiol; 2011 Jul; 60(Pt 7):961-967. PubMed ID: 21393452
[TBL] [Abstract][Full Text] [Related]
5. The pathology of human and murine pulmonary infection with Cryptococcus neoformans var. gattii.
Torda A; Kumar RK; Jones PD
Pathology; 2001 Nov; 33(4):475-8. PubMed ID: 11827415
[TBL] [Abstract][Full Text] [Related]
6. A unique chromosomal rearrangement in the Cryptococcus neoformans var. grubii type strain enhances key phenotypes associated with virulence.
Morrow CA; Lee IR; Chow EW; Ormerod KL; Goldinger A; Byrnes EJ; Nielsen K; Heitman J; Schirra HJ; Fraser JA
mBio; 2012; 3(2):. PubMed ID: 22375073
[TBL] [Abstract][Full Text] [Related]
7. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
Chan M; Lye D; Win MK; Chow A; Barkham T
Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
[TBL] [Abstract][Full Text] [Related]
8. Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line.
Olave MC; Vargas-Zambrano JC; Celis AM; Castañeda E; González JM
Mycoses; 2017 Jul; 60(7):447-453. PubMed ID: 28338245
[TBL] [Abstract][Full Text] [Related]
9. Cryptococcus neoformans varieties as agents of cryptococcosis in Brazil.
Rozenbaum R; Gonçalves AJ; Wanke B; Caiuby MJ; Clemente H; Lazera Mdos S; Monteiro PC; Londero AT
Mycopathologia; 1992 Sep; 119(3):133-6. PubMed ID: 1435954
[TBL] [Abstract][Full Text] [Related]
10. Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.
Leongson K; Cousineau-Côté V; Goupil M; Aumont F; Sénéchal S; Gaboury L; Jolicoeur P; Kronstad JW; de Repentigny L
Infect Immun; 2013 Apr; 81(4):1100-13. PubMed ID: 23340313
[TBL] [Abstract][Full Text] [Related]
11. Seasonal prevalence of Cryptococcus neoformans var. grubii and Cryptococcus gattii inhabiting Eucalyptus terreticornis and Eucalyptus camaldulensis trees in Jabalpur City of Madhya Pradesh, Central India.
Bedi NG; Nawange SR; Singh SM; Naidu J; Kavishwar A
J Mycol Med; 2012 Dec; 22(4):341-7. PubMed ID: 23518169
[TBL] [Abstract][Full Text] [Related]
12. [Fungal infection induced by Cryptococcus neoformans aerosol inhalation in immunosuppressed Balb/c mice].
Fu M; Wang Y; Lin Y; Zhang L; Luo W; Zhao T; Long M; Cao H
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):169-72. PubMed ID: 22381750
[TBL] [Abstract][Full Text] [Related]
13. Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia.
Yang JH; Huang PY; Cheng CW; Shie SS; Lin ZF; Yang LY; Lee CH; Wu TS
Med Mycol; 2021 Nov; 59(11):1114-1121. PubMed ID: 34374784
[TBL] [Abstract][Full Text] [Related]
14. [Cryptococcus Neoformans Var. Gattii meningoencephalitis with cryptococcoma in an immunocompetent patient successfully treated by surgical resection].
Inada T; Imamura H; Kawamoto M; Sekiya H; Imai Y; Tani S; Adachi H; Ishikawa T; Mineharu Y; Asai K; Ikeda H; Ogura T; Shibata T; Beppu M; Agawa Y; Shimizu K; Sakai N; Kikuchi H
No Shinkei Geka; 2014 Feb; 42(2):123-7. PubMed ID: 24501185
[TBL] [Abstract][Full Text] [Related]
15. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.
Ngamskulrungroj P; Chang Y; Sionov E; Kwon-Chung KJ
mBio; 2012; 3(3):. PubMed ID: 22570277
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and specificities of Cryptococcus infections in French Guiana, 1998-2008.
Debourgogne A; Iriart X; Blanchet D; Veron V; Boukhari R; Nacher M; Carme B; Aznar C
Med Mycol; 2011 Nov; 49(8):864-71. PubMed ID: 21612563
[TBL] [Abstract][Full Text] [Related]
17. Environmental prevalence of Cryptococcus neoformans and Cryptococcus gattii in India: an update.
Chowdhary A; Rhandhawa HS; Prakash A; Meis JF
Crit Rev Microbiol; 2012 Feb; 38(1):1-16. PubMed ID: 22133016
[TBL] [Abstract][Full Text] [Related]
18. The Southeastern Asian house mouse (Mus musculus castaneus Linn.) as a new passenger host for Cryptococcus neoformans var. grubii molecular type VNI.
Singh K; Rani J; Neelabh ; Rai GK; Singh M
Med Mycol; 2017 Nov; 55(8):820-827. PubMed ID: 28204573
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility testing of amphotericin B for Cryptococcus neoformans variety grubii AFLP1/VNI and Cryptococcus gattii AFLP6/VGII by CLSI and flow cytometry.
Morales BP; Trilles L; Bertho ÁL; Junior IN; de Oliveira Rde V; Wanke B; Lazéra Mdos S
Mycoses; 2015 May; 58(5):273-9. PubMed ID: 25756839
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcus neoformans variety gattii.
Sorrell TC
Med Mycol; 2001 Apr; 39(2):155-68. PubMed ID: 11346263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
